High-resolution genome-wide analysis of chromosomal alterations in elastofibroma

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Elastofibroma is a rare, benign fibrous proliferation typically found in periscapular soft tissues.
• Its etiology is unknown, though it's often considered a reactive process or a fibroblastic pseudotumor.
• Previous cytogenetic studies indicated chromosomal instability, raising questions about a possible neoplastic nature.

Observation:

• This study investigated two cases of elastofibroma using array-based comparative genomic hybridization (aCGH) and multiplex ligation-dependent probe amplification (MLPA).
• Both cases exhibited chromosomal losses on 1p, 13q, 19p, and 22q via aCGH.
• MLPA identified deletions in CASR, GSTP1, and BRCA2, along with gains in APC and PAH in both samples.

Findings:

• Genomic alterations, including specific chromosomal losses and gains, were consistently detected in the analyzed elastofibroma cases.
• The identified genomic imbalances suggest a potential role for specific genes in the development of elastofibroma.
• The findings challenge the purely reactive hypothesis and support the consideration of elastofibroma as a neoplastic entity.

Implications:

• Understanding the genomic landscape of elastofibroma is crucial for elucidating its pathogenesis.
• Further genomic screening may identify key genes and pathways involved in elastofibroma development.
• This research contributes to the differential diagnosis and potential future therapeutic strategies for this rare tumor.